GlassScriptPhysician profile
Colin B Harris
NPI 1194979435
$43,396.66
in general payments reported to CMS, 2019-2025
35 companies · $4,270 in 2025
The $4,270 reported for 2025 was more than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,442 · 2020: $3,542 · 2021: $12K · 2022: $5,252 · 2023: $14K · 2024: $2,675 · 2025: $4,270.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Consulting Fee: $5,500 · Travel and Lodging: $4,692.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,647.30 |
| Consulting Fee | $5,500.00 |
| Travel and Lodging | $4,692.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $14,894.20 | 2019-2023 | Xlif, Acp, Tlif |
| Surgalign Spine Technologies, INC. | $10,366.30 | 2020-2021 | |
| Stryker Corporation | $3,114.27 | 2019-2025 | Everest Spinal System, Capri Corpectomy Cage System, Yukon Oct Spinal System |
| Globus Medical, INC. | $2,716.96 | 2019-2025 | Xlif, Simplify Cervical Artificial Disc, Mars |
| Medtronic, INC. | $2,348.66 | 2021-2025 | Mazor X System, Infinity Occipitocervical Upper Thoracic System, Unid_pass |
| Baxter Healthcare | $2,102.48 | 2019-2024 | Actifuse |
| Alphatec Spine, INC | $1,791.68 | 2019-2025 | Lif, Other - Miscellaneous, Invictus Mis |
| Si-Bone, INC. | $811.53 | 2020-2023 | |
| Viseon, INC. | $635.52 | 2021-2025 | Maxview System - Lateral Set |
| Acuity Surgical Devices, LLC | $478.86 | 2025 | |
| Medtronic USA, INC. | $345.91 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $343.86 | 2023 | Iovera, Exparel, Zilretta |
| Boston Scientific Corporation | $343.23 | 2019-2025 | General - Pain Management |
| Royal Biologics, INC. | $303.84 | 2024-2025 | |
| Bioventus LLC | $285.71 | 2019-2025 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Highridge Medical LLC | $259.91 | 2024-2025 | Mobi-C Plug & Fit US, Vital |
| Nevro Corp. | $256.04 | 2021-2024 | Senza |
| Biocomposites INC | $238.08 | 2024 | |
| Spinal Elements, INC. | $232.96 | 2025 | |
| Integrity Implants INC. | $192.69 | 2019-2020 | |
| Cerapedics INC. | $180.34 | 2022-2025 | I-Factor Peptide Enhanced Bone Graft |
| Kuros Biosciences USA, INC | $168.17 | 2023-2025 | Magnetos |
| Providence Medical Technology, INC. | $158.17 | 2025 | |
| Medical Device Business Services, INC. | $142.85 | 2022 | |
| 4web, INC. | $136.36 | 2025 | Spine Truss System |
| Seaspine Orthopedics Corporation | $135.75 | 2021 | |
| Shionogi INC | $109.65 | 2024 | Fetroja |
| Octapharma USA, INC. | $100.00 | 2025 | Balfaxar |
| Seapearl East, INC | $49.80 | 2025 | |
| Checkpoint Surgical, INC | $49.34 | 2023 | Checkpoint Stimulators |
| Saluda Medical Americas, INC. | $33.77 | 2024 | Evoke |
| Ebi, LLC | $25.27 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Merck Sharp & Dohme LLC | $17.26 | 2025 | Zerbaxa |
| Theragen, INC. | $15.00 | 2023 | Actastim-S |
| Zimmer Biomet Holdings, INC. | $12.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Colin Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.